(Q34658867)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

3 August 2017

3 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

https://github.com/jmillanacosta/retractable/blob/e28dcac33244e89948fe17fb65f09b59e2ed804d/data/PMIDS_DOIS.csv

title

Correlation of CD44v6 expression with ovarian cancer progression and recurrence (English)

1 reference

3 August 2017

1 reference

Jun Shi

1

1 reference

3 August 2017

Zhou Zhou

series ordinal

2

1 reference

3 August 2017

Wen Di

series ordinal

3

1 reference

3 August 2017

Ningli Li

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

8 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

182

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-182

3 August 2017

0 references

cites work

Understanding the dual nature of CD44 in breast cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Rethinking ovarian cancer: recommendations for improving outcomes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

7 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

CD44 in hematological neoplasias

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

The biology of ovarian cancer: new opportunities for translation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

CD44 cell adhesion molecules

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Micrometastases formation: a probabilistic model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

The genesis and evolution of high-grade serous ovarian cancer.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

Biology of fetal wound healing: hyaluronate receptor expression in fetal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

Serum CD44 levels and overall survival in patients with HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

Prevention of tumor metastasis formation by anti-variant CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-182

CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3635997

CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer

26 October 2018

1 reference

12 December 2020

Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules

1 reference

12 December 2020

Localization of hyaluronan in mouse embryos during implantation, gastrulation and organogenesis

1 reference

12 December 2020

Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer

1 reference

12 December 2020

Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis

1 reference

12 December 2020

Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice

1 reference

12 December 2020

Comparison of p53 and CD44 variant 6 expression between paired primary and recurrent ovarian cancer: an immunohistochemical analysis

1 reference

12 December 2020

Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer

1 reference

12 December 2020

CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression

1 reference

12 December 2020

Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients

1 reference

12 December 2020

[Study on the relationship between CD44v6, p53 gene mutation and ovarian carcinoma metastasis]

1 reference

12 December 2020

[Clinical significance of CD44 expression in ovarian epithelial tumors]

1 reference

12 December 2020

[Expression of CD44v6 and E-cadherin in prostate carcinoma and metastasis of prostate carcinoma]

1 reference

12 December 2020

Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity

1 reference

12 December 2020

The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11

1 reference

12 December 2020

Significance of CD44v6 expression in gynecologic malignancies

1 reference

12 December 2020

Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors

1 reference

12 December 2020

Introduction: what are new roles of current colonoscopy?

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1186/1471-2407-13-182

9 February 2024

Identifiers

DOI

10.1186/1471-2407-13-182

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference